5-amino-1mq 10mg – SYD PEPTIDES HUB 5-Amino-1MQ 10 mg Research Compound

The efficacy of ABILIFY MAINTENA for the maintenance treatment of bipolar I disorder was established in a 52-week, double-blind, placebo-controlled, randomized withdrawal trial in adult patients who were experiencing a manic episode at trial entry, met DSM-IV-TR criteria for bipolar I disorder, and had a history of at least one previous manic or mixed episode with manic symptoms of sufficient severity to require one of the following interventions: hospitalization and/or treatment with a mood stabilizer, and/or treatment with an antipsychotic agent

How the Process Works

HCPCS Code J8499 is a Level II billing code for a prescription drug that is oral, non-chemotherapeutic, and not otherwise specified by a more specific J-code

Common side effects may include pain or redness at the injection site